Baidu
map

NEJM:脾脏移位-病例报道

2020-11-19 MedSci原创 MedSci原创

脾脏移位是脾脏韧带松弛导致的罕见病。随着脾脏的移动,可能导致脾门内或脾门附近结构的扭曲,包括胰腺尾巴,这可能会导致急性胰腺炎。对于这种情况的明确治疗是脾切除术。

患者为一名36岁的妇女因腹痛和呕吐1天,而到急诊就诊。她患有溃疡性结肠炎以及因原发性硬化性胆管炎而导致的肝硬化,她的手术史包括全结肠切除术,胆囊切除术和阑尾切除术。

体格检查发现腹部弥漫性压痛。实验室检查发现脂肪酶水平为682 IU/L(参考范围为5至50)。腹部计算机断层扫描发现脾脏位于右下象限(如图A星号所示),胰尾部位于下方和右侧。在本次就诊前两天,患者已通过磁共振胆胰胰管造影术进行了肝细胞癌的常规筛查,该检查显示脾脏位于腹部左侧(如图B星号所示),以及胰腺正常,未见胆结石。

脾脏移位是脾脏韧带松弛导致的罕见病。随着脾脏的移动,可能导致脾门内或脾门附近结构的扭曲,包括胰腺尾巴,这可能会导致急性胰腺炎。对于这种情况的明确治疗是脾切除术。

该患者接受了肠胃外疼痛控制治疗和补液治疗,腹痛和呕吐得以缓解。由于该患者正在进行肝移植评估,因此推迟了脾切除术。

原始出处:

Alexander Wester,et al.Wandering Spleen.N Engl J Med.2020;https://www.nejm.org/doi/full/10.1056/NEJMicm2003627

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=902531, encodeId=f46090253189, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqgjrd5sqia9SxoRDrrHyGx1rdtniayrW3OZxZq1ZFwnic0zYSSLeowYhMR0cNFfhHbRZuPcJQfMd9WQ/132, createdBy=22452183242, createdName=海盗船长, createdTime=Thu Nov 26 16:51:54 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900963, encodeId=ff9b9009639c, content=学习病例, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200925/715f77a9a29d4907967d9aff0401c7dd/e9332ce2f0474cf4bcce214162b301b2.jpg, createdBy=07f32537611, createdName=追逐着, createdTime=Sat Nov 21 10:29:16 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900695, encodeId=1d5d90069534, content=非常好的病例, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201124/2e41e368c07d43d294a6e1733a82ef72/41673fa4f0584c08b9e0741da72c3008.jpg, createdBy=a36e5436504, createdName=ms3000001818868558, createdTime=Fri Nov 20 07:58:07 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900455, encodeId=e20790045529, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Thu Nov 19 13:14:56 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035500, encodeId=a2e410355000b, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Nov 19 11:14:12 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900405, encodeId=aed190040569, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3055395222, createdName=ms4000001317950635, createdTime=Thu Nov 19 10:24:15 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900397, encodeId=cb0b90039e1c, content=学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68692513618, createdName=124c4ba8m65暂无昵称, createdTime=Thu Nov 19 09:54:25 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900388, encodeId=11d29003883d, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6a51476719, createdName=titiwangsunny, createdTime=Thu Nov 19 09:38:15 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900379, encodeId=58049003e9f8, content=666, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201119/797a4bfb014344ef9aaf61d4e9e70516/9b7bea42f7d4451eb7049db4faed2274.jpg, createdBy=2cba5436368, createdName=ms8000001960994722, createdTime=Thu Nov 19 09:25:37 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900369, encodeId=a268900369d6, content=学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201119/b67c8afa4ea8415488135a3c0aeb7e2a/64ac537f3a264073af97e54401434211.jpg, createdBy=a3c05436358, createdName=ms3000000722898900, createdTime=Thu Nov 19 08:57:50 CST 2020, time=2020-11-19, status=1, ipAttribution=)]
    2020-11-26 海盗船长

    好文章!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=902531, encodeId=f46090253189, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqgjrd5sqia9SxoRDrrHyGx1rdtniayrW3OZxZq1ZFwnic0zYSSLeowYhMR0cNFfhHbRZuPcJQfMd9WQ/132, createdBy=22452183242, createdName=海盗船长, createdTime=Thu Nov 26 16:51:54 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900963, encodeId=ff9b9009639c, content=学习病例, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200925/715f77a9a29d4907967d9aff0401c7dd/e9332ce2f0474cf4bcce214162b301b2.jpg, createdBy=07f32537611, createdName=追逐着, createdTime=Sat Nov 21 10:29:16 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900695, encodeId=1d5d90069534, content=非常好的病例, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201124/2e41e368c07d43d294a6e1733a82ef72/41673fa4f0584c08b9e0741da72c3008.jpg, createdBy=a36e5436504, createdName=ms3000001818868558, createdTime=Fri Nov 20 07:58:07 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900455, encodeId=e20790045529, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Thu Nov 19 13:14:56 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035500, encodeId=a2e410355000b, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Nov 19 11:14:12 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900405, encodeId=aed190040569, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3055395222, createdName=ms4000001317950635, createdTime=Thu Nov 19 10:24:15 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900397, encodeId=cb0b90039e1c, content=学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68692513618, createdName=124c4ba8m65暂无昵称, createdTime=Thu Nov 19 09:54:25 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900388, encodeId=11d29003883d, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6a51476719, createdName=titiwangsunny, createdTime=Thu Nov 19 09:38:15 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900379, encodeId=58049003e9f8, content=666, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201119/797a4bfb014344ef9aaf61d4e9e70516/9b7bea42f7d4451eb7049db4faed2274.jpg, createdBy=2cba5436368, createdName=ms8000001960994722, createdTime=Thu Nov 19 09:25:37 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900369, encodeId=a268900369d6, content=学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201119/b67c8afa4ea8415488135a3c0aeb7e2a/64ac537f3a264073af97e54401434211.jpg, createdBy=a3c05436358, createdName=ms3000000722898900, createdTime=Thu Nov 19 08:57:50 CST 2020, time=2020-11-19, status=1, ipAttribution=)]
    2020-11-21 追逐着

    学习病例

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=902531, encodeId=f46090253189, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqgjrd5sqia9SxoRDrrHyGx1rdtniayrW3OZxZq1ZFwnic0zYSSLeowYhMR0cNFfhHbRZuPcJQfMd9WQ/132, createdBy=22452183242, createdName=海盗船长, createdTime=Thu Nov 26 16:51:54 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900963, encodeId=ff9b9009639c, content=学习病例, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200925/715f77a9a29d4907967d9aff0401c7dd/e9332ce2f0474cf4bcce214162b301b2.jpg, createdBy=07f32537611, createdName=追逐着, createdTime=Sat Nov 21 10:29:16 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900695, encodeId=1d5d90069534, content=非常好的病例, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201124/2e41e368c07d43d294a6e1733a82ef72/41673fa4f0584c08b9e0741da72c3008.jpg, createdBy=a36e5436504, createdName=ms3000001818868558, createdTime=Fri Nov 20 07:58:07 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900455, encodeId=e20790045529, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Thu Nov 19 13:14:56 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035500, encodeId=a2e410355000b, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Nov 19 11:14:12 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900405, encodeId=aed190040569, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3055395222, createdName=ms4000001317950635, createdTime=Thu Nov 19 10:24:15 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900397, encodeId=cb0b90039e1c, content=学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68692513618, createdName=124c4ba8m65暂无昵称, createdTime=Thu Nov 19 09:54:25 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900388, encodeId=11d29003883d, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6a51476719, createdName=titiwangsunny, createdTime=Thu Nov 19 09:38:15 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900379, encodeId=58049003e9f8, content=666, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201119/797a4bfb014344ef9aaf61d4e9e70516/9b7bea42f7d4451eb7049db4faed2274.jpg, createdBy=2cba5436368, createdName=ms8000001960994722, createdTime=Thu Nov 19 09:25:37 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900369, encodeId=a268900369d6, content=学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201119/b67c8afa4ea8415488135a3c0aeb7e2a/64ac537f3a264073af97e54401434211.jpg, createdBy=a3c05436358, createdName=ms3000000722898900, createdTime=Thu Nov 19 08:57:50 CST 2020, time=2020-11-19, status=1, ipAttribution=)]
    2020-11-20 ms3000001818868558

    非常好的病例

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=902531, encodeId=f46090253189, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqgjrd5sqia9SxoRDrrHyGx1rdtniayrW3OZxZq1ZFwnic0zYSSLeowYhMR0cNFfhHbRZuPcJQfMd9WQ/132, createdBy=22452183242, createdName=海盗船长, createdTime=Thu Nov 26 16:51:54 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900963, encodeId=ff9b9009639c, content=学习病例, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200925/715f77a9a29d4907967d9aff0401c7dd/e9332ce2f0474cf4bcce214162b301b2.jpg, createdBy=07f32537611, createdName=追逐着, createdTime=Sat Nov 21 10:29:16 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900695, encodeId=1d5d90069534, content=非常好的病例, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201124/2e41e368c07d43d294a6e1733a82ef72/41673fa4f0584c08b9e0741da72c3008.jpg, createdBy=a36e5436504, createdName=ms3000001818868558, createdTime=Fri Nov 20 07:58:07 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900455, encodeId=e20790045529, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Thu Nov 19 13:14:56 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035500, encodeId=a2e410355000b, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Nov 19 11:14:12 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900405, encodeId=aed190040569, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3055395222, createdName=ms4000001317950635, createdTime=Thu Nov 19 10:24:15 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900397, encodeId=cb0b90039e1c, content=学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68692513618, createdName=124c4ba8m65暂无昵称, createdTime=Thu Nov 19 09:54:25 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900388, encodeId=11d29003883d, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6a51476719, createdName=titiwangsunny, createdTime=Thu Nov 19 09:38:15 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900379, encodeId=58049003e9f8, content=666, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201119/797a4bfb014344ef9aaf61d4e9e70516/9b7bea42f7d4451eb7049db4faed2274.jpg, createdBy=2cba5436368, createdName=ms8000001960994722, createdTime=Thu Nov 19 09:25:37 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900369, encodeId=a268900369d6, content=学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201119/b67c8afa4ea8415488135a3c0aeb7e2a/64ac537f3a264073af97e54401434211.jpg, createdBy=a3c05436358, createdName=ms3000000722898900, createdTime=Thu Nov 19 08:57:50 CST 2020, time=2020-11-19, status=1, ipAttribution=)]
    2020-11-19 Baodongxu

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=902531, encodeId=f46090253189, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqgjrd5sqia9SxoRDrrHyGx1rdtniayrW3OZxZq1ZFwnic0zYSSLeowYhMR0cNFfhHbRZuPcJQfMd9WQ/132, createdBy=22452183242, createdName=海盗船长, createdTime=Thu Nov 26 16:51:54 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900963, encodeId=ff9b9009639c, content=学习病例, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200925/715f77a9a29d4907967d9aff0401c7dd/e9332ce2f0474cf4bcce214162b301b2.jpg, createdBy=07f32537611, createdName=追逐着, createdTime=Sat Nov 21 10:29:16 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900695, encodeId=1d5d90069534, content=非常好的病例, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201124/2e41e368c07d43d294a6e1733a82ef72/41673fa4f0584c08b9e0741da72c3008.jpg, createdBy=a36e5436504, createdName=ms3000001818868558, createdTime=Fri Nov 20 07:58:07 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900455, encodeId=e20790045529, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Thu Nov 19 13:14:56 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035500, encodeId=a2e410355000b, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Nov 19 11:14:12 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900405, encodeId=aed190040569, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3055395222, createdName=ms4000001317950635, createdTime=Thu Nov 19 10:24:15 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900397, encodeId=cb0b90039e1c, content=学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68692513618, createdName=124c4ba8m65暂无昵称, createdTime=Thu Nov 19 09:54:25 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900388, encodeId=11d29003883d, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6a51476719, createdName=titiwangsunny, createdTime=Thu Nov 19 09:38:15 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900379, encodeId=58049003e9f8, content=666, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201119/797a4bfb014344ef9aaf61d4e9e70516/9b7bea42f7d4451eb7049db4faed2274.jpg, createdBy=2cba5436368, createdName=ms8000001960994722, createdTime=Thu Nov 19 09:25:37 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900369, encodeId=a268900369d6, content=学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201119/b67c8afa4ea8415488135a3c0aeb7e2a/64ac537f3a264073af97e54401434211.jpg, createdBy=a3c05436358, createdName=ms3000000722898900, createdTime=Thu Nov 19 08:57:50 CST 2020, time=2020-11-19, status=1, ipAttribution=)]
    2020-11-19 旺医

    顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=902531, encodeId=f46090253189, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqgjrd5sqia9SxoRDrrHyGx1rdtniayrW3OZxZq1ZFwnic0zYSSLeowYhMR0cNFfhHbRZuPcJQfMd9WQ/132, createdBy=22452183242, createdName=海盗船长, createdTime=Thu Nov 26 16:51:54 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900963, encodeId=ff9b9009639c, content=学习病例, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200925/715f77a9a29d4907967d9aff0401c7dd/e9332ce2f0474cf4bcce214162b301b2.jpg, createdBy=07f32537611, createdName=追逐着, createdTime=Sat Nov 21 10:29:16 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900695, encodeId=1d5d90069534, content=非常好的病例, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201124/2e41e368c07d43d294a6e1733a82ef72/41673fa4f0584c08b9e0741da72c3008.jpg, createdBy=a36e5436504, createdName=ms3000001818868558, createdTime=Fri Nov 20 07:58:07 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900455, encodeId=e20790045529, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Thu Nov 19 13:14:56 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035500, encodeId=a2e410355000b, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Nov 19 11:14:12 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900405, encodeId=aed190040569, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3055395222, createdName=ms4000001317950635, createdTime=Thu Nov 19 10:24:15 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900397, encodeId=cb0b90039e1c, content=学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68692513618, createdName=124c4ba8m65暂无昵称, createdTime=Thu Nov 19 09:54:25 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900388, encodeId=11d29003883d, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6a51476719, createdName=titiwangsunny, createdTime=Thu Nov 19 09:38:15 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900379, encodeId=58049003e9f8, content=666, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201119/797a4bfb014344ef9aaf61d4e9e70516/9b7bea42f7d4451eb7049db4faed2274.jpg, createdBy=2cba5436368, createdName=ms8000001960994722, createdTime=Thu Nov 19 09:25:37 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900369, encodeId=a268900369d6, content=学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201119/b67c8afa4ea8415488135a3c0aeb7e2a/64ac537f3a264073af97e54401434211.jpg, createdBy=a3c05436358, createdName=ms3000000722898900, createdTime=Thu Nov 19 08:57:50 CST 2020, time=2020-11-19, status=1, ipAttribution=)]
    2020-11-19 ms4000001317950635

    好的

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=902531, encodeId=f46090253189, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqgjrd5sqia9SxoRDrrHyGx1rdtniayrW3OZxZq1ZFwnic0zYSSLeowYhMR0cNFfhHbRZuPcJQfMd9WQ/132, createdBy=22452183242, createdName=海盗船长, createdTime=Thu Nov 26 16:51:54 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900963, encodeId=ff9b9009639c, content=学习病例, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200925/715f77a9a29d4907967d9aff0401c7dd/e9332ce2f0474cf4bcce214162b301b2.jpg, createdBy=07f32537611, createdName=追逐着, createdTime=Sat Nov 21 10:29:16 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900695, encodeId=1d5d90069534, content=非常好的病例, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201124/2e41e368c07d43d294a6e1733a82ef72/41673fa4f0584c08b9e0741da72c3008.jpg, createdBy=a36e5436504, createdName=ms3000001818868558, createdTime=Fri Nov 20 07:58:07 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900455, encodeId=e20790045529, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Thu Nov 19 13:14:56 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035500, encodeId=a2e410355000b, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Nov 19 11:14:12 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900405, encodeId=aed190040569, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3055395222, createdName=ms4000001317950635, createdTime=Thu Nov 19 10:24:15 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900397, encodeId=cb0b90039e1c, content=学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68692513618, createdName=124c4ba8m65暂无昵称, createdTime=Thu Nov 19 09:54:25 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900388, encodeId=11d29003883d, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6a51476719, createdName=titiwangsunny, createdTime=Thu Nov 19 09:38:15 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900379, encodeId=58049003e9f8, content=666, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201119/797a4bfb014344ef9aaf61d4e9e70516/9b7bea42f7d4451eb7049db4faed2274.jpg, createdBy=2cba5436368, createdName=ms8000001960994722, createdTime=Thu Nov 19 09:25:37 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900369, encodeId=a268900369d6, content=学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201119/b67c8afa4ea8415488135a3c0aeb7e2a/64ac537f3a264073af97e54401434211.jpg, createdBy=a3c05436358, createdName=ms3000000722898900, createdTime=Thu Nov 19 08:57:50 CST 2020, time=2020-11-19, status=1, ipAttribution=)]
    2020-11-19 124c4ba8m65暂无昵称

    学习中

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=902531, encodeId=f46090253189, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqgjrd5sqia9SxoRDrrHyGx1rdtniayrW3OZxZq1ZFwnic0zYSSLeowYhMR0cNFfhHbRZuPcJQfMd9WQ/132, createdBy=22452183242, createdName=海盗船长, createdTime=Thu Nov 26 16:51:54 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900963, encodeId=ff9b9009639c, content=学习病例, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200925/715f77a9a29d4907967d9aff0401c7dd/e9332ce2f0474cf4bcce214162b301b2.jpg, createdBy=07f32537611, createdName=追逐着, createdTime=Sat Nov 21 10:29:16 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900695, encodeId=1d5d90069534, content=非常好的病例, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201124/2e41e368c07d43d294a6e1733a82ef72/41673fa4f0584c08b9e0741da72c3008.jpg, createdBy=a36e5436504, createdName=ms3000001818868558, createdTime=Fri Nov 20 07:58:07 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900455, encodeId=e20790045529, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Thu Nov 19 13:14:56 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035500, encodeId=a2e410355000b, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Nov 19 11:14:12 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900405, encodeId=aed190040569, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3055395222, createdName=ms4000001317950635, createdTime=Thu Nov 19 10:24:15 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900397, encodeId=cb0b90039e1c, content=学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68692513618, createdName=124c4ba8m65暂无昵称, createdTime=Thu Nov 19 09:54:25 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900388, encodeId=11d29003883d, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6a51476719, createdName=titiwangsunny, createdTime=Thu Nov 19 09:38:15 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900379, encodeId=58049003e9f8, content=666, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201119/797a4bfb014344ef9aaf61d4e9e70516/9b7bea42f7d4451eb7049db4faed2274.jpg, createdBy=2cba5436368, createdName=ms8000001960994722, createdTime=Thu Nov 19 09:25:37 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900369, encodeId=a268900369d6, content=学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201119/b67c8afa4ea8415488135a3c0aeb7e2a/64ac537f3a264073af97e54401434211.jpg, createdBy=a3c05436358, createdName=ms3000000722898900, createdTime=Thu Nov 19 08:57:50 CST 2020, time=2020-11-19, status=1, ipAttribution=)]
    2020-11-19 titiwangsunny

    谢谢

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=902531, encodeId=f46090253189, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqgjrd5sqia9SxoRDrrHyGx1rdtniayrW3OZxZq1ZFwnic0zYSSLeowYhMR0cNFfhHbRZuPcJQfMd9WQ/132, createdBy=22452183242, createdName=海盗船长, createdTime=Thu Nov 26 16:51:54 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900963, encodeId=ff9b9009639c, content=学习病例, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200925/715f77a9a29d4907967d9aff0401c7dd/e9332ce2f0474cf4bcce214162b301b2.jpg, createdBy=07f32537611, createdName=追逐着, createdTime=Sat Nov 21 10:29:16 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900695, encodeId=1d5d90069534, content=非常好的病例, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201124/2e41e368c07d43d294a6e1733a82ef72/41673fa4f0584c08b9e0741da72c3008.jpg, createdBy=a36e5436504, createdName=ms3000001818868558, createdTime=Fri Nov 20 07:58:07 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900455, encodeId=e20790045529, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Thu Nov 19 13:14:56 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035500, encodeId=a2e410355000b, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Nov 19 11:14:12 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900405, encodeId=aed190040569, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3055395222, createdName=ms4000001317950635, createdTime=Thu Nov 19 10:24:15 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900397, encodeId=cb0b90039e1c, content=学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68692513618, createdName=124c4ba8m65暂无昵称, createdTime=Thu Nov 19 09:54:25 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900388, encodeId=11d29003883d, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6a51476719, createdName=titiwangsunny, createdTime=Thu Nov 19 09:38:15 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900379, encodeId=58049003e9f8, content=666, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201119/797a4bfb014344ef9aaf61d4e9e70516/9b7bea42f7d4451eb7049db4faed2274.jpg, createdBy=2cba5436368, createdName=ms8000001960994722, createdTime=Thu Nov 19 09:25:37 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900369, encodeId=a268900369d6, content=学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201119/b67c8afa4ea8415488135a3c0aeb7e2a/64ac537f3a264073af97e54401434211.jpg, createdBy=a3c05436358, createdName=ms3000000722898900, createdTime=Thu Nov 19 08:57:50 CST 2020, time=2020-11-19, status=1, ipAttribution=)]
    2020-11-19 ms8000001960994722

    666

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=902531, encodeId=f46090253189, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqgjrd5sqia9SxoRDrrHyGx1rdtniayrW3OZxZq1ZFwnic0zYSSLeowYhMR0cNFfhHbRZuPcJQfMd9WQ/132, createdBy=22452183242, createdName=海盗船长, createdTime=Thu Nov 26 16:51:54 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900963, encodeId=ff9b9009639c, content=学习病例, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200925/715f77a9a29d4907967d9aff0401c7dd/e9332ce2f0474cf4bcce214162b301b2.jpg, createdBy=07f32537611, createdName=追逐着, createdTime=Sat Nov 21 10:29:16 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900695, encodeId=1d5d90069534, content=非常好的病例, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201124/2e41e368c07d43d294a6e1733a82ef72/41673fa4f0584c08b9e0741da72c3008.jpg, createdBy=a36e5436504, createdName=ms3000001818868558, createdTime=Fri Nov 20 07:58:07 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900455, encodeId=e20790045529, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Thu Nov 19 13:14:56 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035500, encodeId=a2e410355000b, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Nov 19 11:14:12 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900405, encodeId=aed190040569, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3055395222, createdName=ms4000001317950635, createdTime=Thu Nov 19 10:24:15 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900397, encodeId=cb0b90039e1c, content=学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68692513618, createdName=124c4ba8m65暂无昵称, createdTime=Thu Nov 19 09:54:25 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900388, encodeId=11d29003883d, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6a51476719, createdName=titiwangsunny, createdTime=Thu Nov 19 09:38:15 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900379, encodeId=58049003e9f8, content=666, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201119/797a4bfb014344ef9aaf61d4e9e70516/9b7bea42f7d4451eb7049db4faed2274.jpg, createdBy=2cba5436368, createdName=ms8000001960994722, createdTime=Thu Nov 19 09:25:37 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900369, encodeId=a268900369d6, content=学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201119/b67c8afa4ea8415488135a3c0aeb7e2a/64ac537f3a264073af97e54401434211.jpg, createdBy=a3c05436358, createdName=ms3000000722898900, createdTime=Thu Nov 19 08:57:50 CST 2020, time=2020-11-19, status=1, ipAttribution=)]
    2020-11-19 ms3000000722898900

    学习中

    0

相关资讯

哪些呕吐不能用甲氧氯普胺治疗?

甲氧氯普胺(别名胃复安、灭吐灵)是一种多巴胺D2受体拮抗剂,通过抑制延髓催吐化学感受区,从而发挥强大的中枢性止吐作用,能用于各种原因引起的恶心、呕吐、消化不良的对症治疗。

安徽五河发生疑似食源性疾病事件,55人现呕吐、发烧等症状

5月4日,安徽省五河县县委对外宣传办公室官微“五河发布”通报,5月2日,该县发生一起疑似食源性疾病事件,部分就餐人员出现呕吐、腹泻、发烧等症状。经医院诊查,目前患者均病情稳定。

新生儿呕吐物:是妈妈的血还是宝宝的血?

中午值班接到新生儿科医生电话反映,该科室上午送检的呕吐物是血性标本,但检验结果报告:红细胞镜检偶见,隐血实验:阴性,检验结果与标本存在明显差异,希望我们尽快查找原因,给予答复。听到医生质疑我们的结果,

67岁老汉呕吐、吃不下饭——内镜专家从他胃里挖出来一块“土豆”

患者男,67岁,半年前曾因纳差、腹胀、间歇性呕吐就诊。

NEJM:先天性巨结肠症-病例报道

患者为一名3天大的男婴,因呕吐、无法排便、腹胀和无法母乳喂养而到医院就诊。医务人员取了远端狭窄结肠的全层活检样品;经组织学检查,未见神经节细胞,这一发现证实了诊断。

十年间,她反复腹胀、腹痛、恶心、呕吐、停止排便,原因竟是.....

去年年初,有一个特殊的病人来到西安交大二附院风湿免疫科就诊。该患者是一名45岁的女性,过去10多年间反复出现腹痛、腹胀、恶心、呕吐、停止排便等症状,多次就诊于多家医院消化科,经过一系列检查后,诊断为&

Baidu
map
Baidu
map
Baidu
map